Market cap
$0 Mln
Revenue (TTM)
$-2 Mln
P/E Ratio
--
P/B Ratio
122.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -490.98 | -- | -- |
| EBIT | 37.73 | 62.77 | 27.46 | -10.72 | -22.23 |
| Net Profit | -79.61 | -25.94 | 42.55 | -62.07 | -202.83 |
| EPS | -79.61 | -5.04 | 52.56 | -19.01 | -226.96 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-23 | Mar-22 |
| EBIT-Margin
| -5,768.59 | -5,768.59 | 377.70 | -10,034.83 | -1,502.35 |
| Net Margin
| -- | -62,287.59 | 685.64 | -- | -- |
| Return on equity
| -81.05 | -258.80 | -- | 249.27 | -314.74 |
| Return on Capital
| -64.34 | -233.70 | -- | -101.50 | -52.47 |
| Return on Assets
| -53.30 | -75.96 | -39.20 | -77.15 | -48.43 |
| Debt to Equity (x)
| -- | -- | 0.00 | -1.70 | 41.17 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
--
|
-101.50
|
-52.47
|
-39.06
|
-834.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
--
|
249.27
|
-314.74
|
-177.67
|
-910.37
|
|
Peer Median
|
4.98
|
--
|
--
|
--
|
--
|
ROA
-39.20
Lower than Peers by 41.66
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
-39.20
|
-77.15
|
-48.43
|
-34.33
|
-139.05
|
|
Peer Median
|
2.46
|
--
|
--
|
--
|
--
|
EBIT Margin
377.70
Higher than Peers by 369.17
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
377.70
|
-10,034.83
|
-1,502.35
|
--
|
--
|
|
Peer Median
|
8.53
|
--
|
--
|
--
|
--
|
Net Margin
685.64
Higher than Peers by 680.89
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
685.64
|
-18,358.00
|
-2,755.83
|
--
|
-105,965.26
|
|
Peer Median
|
4.75
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-490.98
Lower than Peers by 499.75
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
-490.98
|
-0.85
|
--
|
--
|
--
|
|
Peer Median
|
8.78
|
--
|
--
|
--
|
--
|
EBIT Growth
27.46
Higher than Peers by 16.43
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
27.46
|
-2.12
|
-65.05
|
4.01
|
-6.74
|
|
Peer Median
|
11.03
|
--
|
--
|
--
|
--
|
Net Profit Growth
42.55
Higher than Peers by 28.80
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
42.55
|
-1.85
|
-121.88
|
-50.44
|
6.57
|
|
Peer Median
|
13.75
|
--
|
--
|
--
|
--
|
EPS Growth
52.56
Higher than Peers by 31.12
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
52.56
|
0.18
|
-1.18
|
-0.37
|
0.07
|
|
Peer Median
|
21.44
|
--
|
--
|
--
|
--
|
Book Value Growth
-50.81
Lower than Peers by 57.63
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
-50.81
|
--
|
--
|
--
|
--
|
|
Peer Median
|
6.82
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
--
|
-1.70
|
41.17
|
2.98
|
-0.06
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-1.10
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
-1.10
|
-1.43
|
41.17
|
0.69
|
-0.70
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.19
Lower than Peers by 2.51
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
0.19
|
0.61
|
0.98
|
5.29
|
0.61
|
|
Peer Median
|
2.70
|
--
|
--
|
--
|
--
|
Quick Ratio
0.03
Lower than Peers by 2.00
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
0.03
|
0.53
|
0.90
|
5.16
|
0.40
|
|
Peer Median
|
2.03
|
--
|
--
|
--
|
--
|
Interest Coverage
-0.88
Lower than Peers by 5.90
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
-0.88
|
-1.21
|
-1.14
|
-2.28
|
-1,217.14
|
|
Peer Median
|
5.02
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
-15.95
Lower than Peers by 32.34
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
-15.95
|
531.71
|
20.10
|
--
|
--
|
|
Peer Median
|
16.39
|
--
|
--
|
--
|
--
|
Asset Turnover
-0.06
Lower than Peers by 0.56
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
-0.06
|
0.00
|
0.02
|
--
|
--
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
--
|
1,211.14
|
69.08
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
--
|
381.21
|
1,240.34
|
2,117.07
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
--
|
54.43
|
206.87
|
1,019.13
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
--
|
1,537.93
|
1,102.56
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
--
|
-1.83
|
-7.34
|
-27.98
|
-29.41
|
|
Peer Median
|
46.09
|
--
|
--
|
--
|
--
|
Price / Book Value
122.56
Higher than Peers by 118.78
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
122.56
|
-2.19
|
218.59
|
20.95
|
-93.19
|
|
Peer Median
|
3.78
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-6.63
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
-6.63
|
-4.91
|
-14.08
|
-37.47
|
-25.90
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
0
Lower than Peers by 535
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
|---|---|---|---|---|---|
|
Nemaura Medical (NMRD)
|
0
|
--
|
--
|
--
|
--
|
|
Peer Median
|
535
|
--
|
--
|
--
|
--
|